REG - Directa Plus PLC - Trading Update and Notice of Results

Directa PlusAnnouncement

27/02/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230227:nRSa0495Ra&default-theme=true

RNS Number : 0495R  Directa Plus PLC  27 February 2023

 

27 February 2023

 

Directa Plus plc

("Directa Plus" or the "Company")

 

Trading Update and Notice of Results

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene
nanoplatelets based products for use in consumer and industrial markets, is
pleased to provide an update on trading for the year ended 31 December 2022
("FY22") and on current trading and outlook.

 

On 2 December 2022, the Company announced that it expected FY22 revenues to be
at least €10.0m, notwithstanding the fulfilment of orders totalling
c.€2.0m being deferred into the new financial year due to the widely
reported supply chain issues. Subject to completion of the audit process, the
Group now expects revenues for FY22 to be not less than €10.8m, as a result
of a strong performance in December, which represents a c.25% increase on the
prior year.

 

This momentum has continued into 2023 with current trading in-line with market
expectations(1) and robust growth across all verticals supported by a
strengthening pipeline of potential opportunities. The current order book for
delivery in 2023 now stands at c. €8.8m, giving the Board confidence in the
Company's continued growth in 2023.

 

Notice of results

The Company expects to announce its audited results for FY22 on 10 May 2023.

 

Giulio Cesareo, Founder and Chief Executive of Directa Plus, commented: "We
made significant progress in FY22, fuelled by several contract wins and an
increasingly supportive market backdrop as large supply chains increasingly
look to incorporate our graphene into products to enhance performance and to
provide more sustainable solutions.  This year, we have demonstrated that our
G+ technology has the ability to sit at the heart of a range of sectors and
serve customers globally.

 

"The Company has entered FY23 in solid position, building on momentum from the
end of the prior year. Our focus now is on developing our core verticals which
are able to generate significant product demand and higher recurring revenue
from customers. With an expanding network of customers and partners, a record
order book and a strong balance sheet, I am confident in the Group's ability
to deliver on its growth ambitions for the year ahead."

 

1)    The Company understands that consensus market expectations for the
year ended 31 December 2023 are for revenues of €13.45m and an EBITDA loss
of -€1.7m (Source: Bloomberg)

 

Enquiries:

 

 Directa Plus plc                                            +39 02 36714458
 Giulio Cesareo, CEO                                         www.directa-plus.com
 Giorgio Bonfanti, CFO

 Cenkos Securities plc (Nominated Adviser and Joint Broker)  +44 131 220 6939
 Neil McDonald
 Adam Rae

 Singer Capital Markets Securities Limited (Joint Broker)    +44 20 7496 3069
 Rick Thompson
 Phil Davies

 Alma PR (Financial PR and IR)                               +44 20 3405 0205
 Justine James                                               directaplus@almapr.co.uk
 Hannah Campbell

 

Notes to Editors

Directa Plus (www.directa-plus.com) is one of the largest producers and
suppliers of graphene-based products for use in consumer and industrial
markets. The Company's graphene manufacturing capability uses proprietary
patented technology based on a plasma super expansion process. Starting from
natural graphite, each step of Directa Plus' production process - expansion,
exfoliation and drying - creates graphene-based materials and hybrid graphene
materials ready for a variety of uses and available in various forms such as
powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product, without
unwanted by-products.  Directa Plus' products are made of hybrid graphene
materials and graphene nano-platelets. The products (marketed as G+®) have
multiple applications due to its properties. These G+® products can be
categorised into various families, with different products being suitable for
specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and
has been listed on the AIM market of the London Stock Exchange since May 2016.
Directa Plus holds the Green Economy Mark from London Stock Exchange which
recognises companies that contribute to the global green economy.

 

This trading update is provided in advance of the financial statements for the
year ended 31 December 2022. The information and commentary provided is based
on unaudited management accounts and other internal performance measures and
is subject to concluding the routine annual accounting adjustments as well as
any adjustments that arise as a result of the external audit
process.  Certain statements made in this trading update are forward-looking
statements. Such statements are based on current expectations and are subject
to a number of risks and uncertainties that could cause actual events or
results to differ materially from any expected future events or results
referred to in these forward-looking statements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTNKQBDOBKDQBB